Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

This local sensation mashes up pop and rock hits with a full brass section, turning every show into a high-energy singalong.

Since its historic FDA approval in March 2024 as the first medication for the treatment of the prevalent liver disease ...

MASH faced an issue that almost no other sitcom has been able to overcome, but this ended up somehow making the classic ...

I messed around and found out how these DIY food dish mash-up taste at New Orleans Jazz Fest. Here's the best of the bunch ...

Madrigal Pharmaceuticals MDGL reported first-quarter 2025 loss of $3.32 per share, narrower than the Zacks Consensus Estimate ...

Utilizing a filamentous fungus in the gut microbiome may provide a new strategy for treating metabolic dysfunction-associated ...

A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition.

A late-stage clinical study showed that this weight loss drug helped 2 out of 3 people with the life-threatening liver ...

Once-weekly semaglutide 2.4 mg significantly reduced steatohepatitis and liver fibrosis symptoms among adults with metabolic ...

Michael Tadros, MD, MPH, discusses how lessons learned from HCV treatment could improve the management of metabolic ...

Prior to starting the trial, the participants also had moderate to high levels of scar tissue in the liver, known as stage 2 ...